Regeneron shares slide on mixed trial data on smoker’s lung drug
(Reuters) -Regeneron shares fell nearly 13% before the bell on Friday after its experimental drug for patients with a type ...
Read moreDetailsTag: experimental drug
Bayer US head says FDA chief reassured pharma executives of timely reviews
By Bhanvi Satija and Michael Erman NEW YORK (Reuters) -Bayer Pharmaceuticals' chief operating officer said the head of the top ...
Read moreDetailsBiogen CEO sees no burning need for more acquisitions
By Deena Beasley SAN FRANCISCO (Reuters) - Biogen expects revenue from new launches to exceed its current sales by 2028 ...
Read moreDetailsChina-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
(Reuters) - Eli Lilly (LLY) and Hong Kong-listed Laekna (2105.HK) will collaborate to develop an experimental obesity drug that aims ...
Read moreDetails
